|
Indice: DAX
ALTANA AG is an international
pharmaceuticals and chemicals group with sales of EUR3.3 billion in 2005
and approx. 13,300 employees all over the world. With a return on sales
(EBT) of around 21%, ALTANA is one of the most profitable pharmaceuticals
and chemicals companies in Europe.
The ALTANA Group is composed
of the strategic management holding company, ALTANA AG, and two operating
divisions, ALTANA Pharma AG and ALTANA Chemie AG. This structure enhances
the flexibility of the individual divisions and enables targeted development.
ALTANA Pharma:
ALTANA Pharma AG, based
in Constance, concentrates on innovative prescription therapeutics. Its
core business comprises gastrointestinal, respiratory tract, and cardiovascular
preparations. In its research, ALTANA Pharma focuses on gastrointestinal
(gastroenterology), respiratory tracts (respiration/anti-inflammation),
and cancer (oncology). Due to high research and development expenses, intelligent
alliances, and the concentration on profitable markets, we have an outstanding
position in global competition.
ALTANA Chemie:
ALTANA Chemie AG, headquartered
in Wesel, has established itself as a global provider of innovative, environmentally
compatible solutions and the corresponding special products for coatings
manufacturers, coatings and plastics processors and the electronics industry.
The product range includes additives, metallic effect pigments, specialty
coatings, sealing and casting compounds, electrical insulation material,
impregnating agents as well as testing and measuring instruments. With
these products, ALTANA Chemie has been successful in selected niche markets
worldwide. All four of its business units are among the leading manufacturers
in their markets.
|